Herbert F.M. Karthaus

4.5k citations

39 papers · 3.6k indexed · 3 hit papers · h-index 20

Molecular Biology top 5%
Pulmonary and Respiratory Medicine top 1%
Cancer Research top 1%
Surgery top 5%
Oncology top 10%

Co-authors: Jack A. Schalken William B. Isaacs Rainy Umbas H. Ewout Schaafsma F M Debruyne F.M.J. Debruyne P P Bringuier J. Alfred Witjes
Topics: Prostate Cancer Diagnosis and Treatment (11 papers)Prostate Cancer Treatment and Research (9 papers)Bladder and Urothelial Cancer Treatments (8 papers)
Cited by: Cancer Research Pulmonary and Respiratory Medicine Urology
Journals: SHILAP Revista de lepidopterologíaClinical Cancer Research The Journal of Urology
Partner nations: Netherlands United States Canada

In The Last Decade

Herbert F.M. Karthaus

39 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.

1999 809 citations Marion J.G. Bussemakers, Adrie van Bokhoven et al. PubMed profile →
DD3PCA3-based Molecular Urine Analysis for the Diagnosis of Prostate Cancer

2003 532 citations Daphne Hessels, Inge M. van Oort et al. European Urology profile →
Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer.

1992 514 citations Rainy Umbas, Jack A. Schalken et al. PubMed profile →

Peers

Countries citing papers authored by Herbert F.M. Karthaus

Since Specialization

Citations

This map shows the geographic impact of Herbert F.M. Karthaus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herbert F.M. Karthaus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herbert F.M. Karthaus more than expected).

Fields of papers citing papers by Herbert F.M. Karthaus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herbert F.M. Karthaus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herbert F.M. Karthaus. The network helps show where Herbert F.M. Karthaus may publish in the future.

Co-authorship network of co-authors of Herbert F.M. Karthaus

This figure shows the co-authorship network connecting the top 25 collaborators of Herbert F.M. Karthaus. A scholar is included among the top collaborators of Herbert F.M. Karthaus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herbert F.M. Karthaus. Herbert F.M. Karthaus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Initial Experience With Identifying High-Grade Prostate Cancer Using Diffusion-Weighted MR Imaging (DWI) in Patients With a Gleason Score ≤3 + 3 = 6 Upon Schematic TRUS-Guided Biopsy 2012 ·Investigative Radiology ·Diederik M. Somford,Thomas Hambrock,Christina A. Hulsbergen‐van de Kaa,Jurgen J. Fütterer,Inge M. van Oort,Jean‐Paul van Basten,Herbert F.M. Karthaus,J. Alfred Witjes,Jelle O. Barentsz	57
2	Biomarkers for the diagnosis of prostatic inflammation in benign prostatic hyperplasia 2011 ·The Prostate ·G. Robert,Frank Smit,Daphne Hessels,Sander A. Jannink,Herbert F.M. Karthaus,Tilly Aalders,(unknown),Alexandre de la Taille,Peter F.A. Mulders,Jack A. Schalken	20
3	Body mass index is not a predictor of biochemical recurrence after radical prostatectomy in Dutch men diagnosed with prostate cancer 2010 ·World Journal of Urology ·Dieuwertje E. Kok,Joep G.H. van Roermund,Katja K.H. Aben,Moniek W.M. van de Luijtgaarden,Herbert F.M. Karthaus,(unknown),Ellen Kampman,J. Alfred Witjes,Lambertus A. Kiemeney	12
4	Brachytherapy versus cystectomy in solitary bladder cancer: A case control, multicentre, East-Netherlands study 2009 ·Radiotherapy and Oncology ·Elzbieta van der Steen-Banasik,Martine Ploeg,J. Alfred Witjes,(unknown),(unknown),(unknown),Herbert F.M. Karthaus,Janny G. Reinders,(unknown),A.G. Visser	27
5	Impact of Obesity on Surgical Outcomes following Open Radical Prostatectomy 2009 ·Urologia Internationalis ·Joep G.H. van Roermund,Jean‐Paul A. van Basten,Lambertus A. Kiemeney,Herbert F.M. Karthaus,J. Alfred Witjes	37
6	Allelic Imbalance Analysis Using a Single-Nucleotide Polymorphism Microarray for the Detection of Bladder Cancer Recurrence 2008 ·Clinical Cancer Research ·Marieke J. H. Coenen,Martine Ploeg,Mascha M.V.A.P. Schijvenaars,Erik B. Cornel,Herbert F.M. Karthaus,Hans Scheffer,J.A. Witjes,Barbara Franke,Lambertus A. Kiemeney	6
7	The prognostic value of E‐cadherin and the cadherin‐associated molecules α‐, β‐, γ‐catenin and p120^ctn in prostate cancer specific survival: A long‐term follow‐up study 2007 ·The Prostate ·Inge M. van Oort,K Tomita,Adrie van Bokhoven,Marion J.G. Bussemakers,Lambertus A. Kiemeney,Herbert F.M. Karthaus,J.A. Witjes,Jack A. Schalken	43
8	UroVysion Compared with Cytology and Quantitative Cytology in the Surveillance of Non–Muscle-Invasive Bladder Cancer 2006 ·European Urology ·Paula M.J. Moonen,Gerard Merkx,(unknown),Herbert F.M. Karthaus,Dominique Smeets,J. Alfred Witjes	83
9	Testicular Granulocytic Sarcoma without Systemic Leukemia 2005 ·Urologia Internationalis ·Brunolf W. Lagerveld,Carla Wauters,Herbert F.M. Karthaus	3
10	Activated Leukocyte Cell Adhesion Molecule (ALCAM) Expression is Associated with a Poor Prognosis for Bladder Cancer Patients 2003 ·K. Tomita,Adrie van Bokhoven,Cornelius F.J. Jansen,Lambertus A. Kiemeney,Herbert F.M. Karthaus,J.L.J. Vriesema,Marion J.G. Bussemakers,J.A. Witjes,Jack A. Schalken	24
11	Laser Treatment of the Prostate Using the Urolase Fiber 1996 ·The Journal of Urology ·(unknown),J. Mooibroek,Theo M. de Reijke,Herbert F.M. Karthaus,(unknown),(unknown),Jean de la Rosette	4
12	Work-Up and Management of Incidentally Found Hypoechoic Lesions of the Testis 1993 ·Urologia Internationalis ·Jean de la Rosette,Herbert F.M. Karthaus,(unknown),(unknown)	2
13	Personality variables involved in chronic prostatitis 1993 ·Urology ·Jean de la Rosette,(unknown),(unknown),Herbert F.M. Karthaus,F.M.J. Debruyne	58
14	Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization. 1993 ·PubMed ·Yahya Tamimi,H.G. Van Der Poel,(unknown),Rainy Umbas,Herbert F.M. Karthaus,F M Debruyne,Jack A. Schalken	118
15	Ultrasonographic findings in patients with nonbacterial prostatitis. 1992 ·Data Archiving and Networked Services (DANS) ·Jean de la Rosette,Herbert F.M. Karthaus,F.M.J. Debruyne	17
16	Results of a Questionnaire among Dutch Urologists and General Practitioners Concerning Diagnostics and Treatment of Patients with Prostatitis Syndromes 1992 ·European Urology ·Jean de la Rosette,(unknown),Herbert F.M. Karthaus,F.M.J. Debruyne	45
17	Research in 'Prostatitis Syndromes':The Use of Alfuzosin (a New α(1)-Receptor-Blocking Agent) in Patients Mainly Presenting with Micturition Complaints of an Irritative Nature and Confirmed Urodynamic Abnormalities 1992 ·European Urology ·Jean J. de la Rosette,Herbert F.M. Karthaus,Philip E.V. van Kerrebroeck,T de Boo,F M Debruyne	51
18	Oncogenes and urological malignancies: Implications for the future 1988 ·Urological Research ·Jack A. Schalken,A.M.W. van den Ouweland,(unknown),Herbert F.M. Karthaus,Wim J.M. Van de Ven	2
19	Expression of proto-oncogenes in xenografts of human renal cell carcinomas 1987 ·Urological Research ·Herbert F.M. Karthaus,Marion J.G. Bussemakers,Jack A. Schalken,K. H. Kurth,Wouter F.J. Feitz,F.M.J. Debruyne,Henri P.J. Bloemers,Wim J.M. Van de Ven	2
20	Results of a Dutch Phase II trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer. 1985 ·PubMed ·F.M.J. Debruyne,Herbert F.M. Karthaus,F.H. Schröder,H. J. de Voogt,Frank H. de Jong,J.G.M. Klijn	11

About Herbert F.M. Karthaus

Herbert F.M. Karthaus is a scholar working on Urology, Rheumatology and Pulmonary and Respiratory Medicine, having authored 39 papers that have together received 3.6k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (11 papers), Prostate Cancer Treatment and Research (9 papers) and Bladder and Urothelial Cancer Treatments (8 papers). The work is most often cited by research in Cancer Research (1.1k citations), Pulmonary and Respiratory Medicine (1.7k citations) and Urology (298 citations). Herbert F.M. Karthaus has collaborated with scholars based in Netherlands, United States and Canada. Frequent co-authors include Jack A. Schalken, William B. Isaacs, Rainy Umbas, H. Ewout Schaafsma, F M Debruyne, F.M.J. Debruyne, P P Bringuier, J. Alfred Witjes, Marion J.G. Bussemakers and Adrie van Bokhoven. Their work appears in journals such as SHILAP Revista de lepidopterología, Clinical Cancer Research and The Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact